CClinicalTrials.gg
CompletedNCT04275843Updated Jul 13, 2022

The Effects of Western Diet Patterns on Plasma Inflammatory and Cardio Metabolic Health Signatures in Middle-aged Adults

An interventional study of Traditional Diet and Modern Diet in Healthy Diet, sponsored by Duke University. Completed at 1 site in United States. Open to participants aged 35 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-13.

Sponsored by Duke University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
21
Allocation
Randomized
Ages
35 Years to 60 Years
Sex
All
01

Study summary

The Western diet pattern or standard American diet is a modern dietary pattern that is characterized by high intakes of meat, pre-packaged foods, fried foods, high-fat dairy products, eggs, refined grains etc. When considering the role of saturated fat, it may be prudent to advise limiting all foods that contain saturated fats, including unprocessed/minimally processed meat, eggs, whole dairy in addition to processed, pre-packaged foods; however, this reductionist approach fails to take into account the food matrix and overall diet in which these nutrients are consumed.

Epidemiological evidence suggests that increased modern, pre-packaged food consumption is a major risk factor for metabolic disease by promoting inflammation. Based on these data, the investigators hypothesize that the pro-atherogenic effect of the Western diet is caused by the pro-inflammatory effects of consuming large amounts of modern ultra-processed foods, and that consumption of a similar amount of fat from minimally processed beef, poultry, dairy, eggs, as part of an unprocessed diet will positively impact inflammatory markers and lipoprotein profiles of study participants when compared to a diet rich in modern ultra-processed foods.

02

Conditions studied

  • Healthy Diet
03

In context

Lead sponsor

Duke University is the lead sponsor of 2,025 studies on the registry; 275 are open to participants now.

Of its 194 completed or terminated interventional studies of FDA-regulated products, 159 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age ≥35 and ≤60 years;
  • BMI ≥25 and ≤35 kg/m2;
  • Weight stable in last 3 months (Loss or gain \<4%);
  • Consistent physical activity levels;
  • Hemoglobin A1C (HbA1C) ≤6.4%;
  • Fasting insulin; \<15 µU/mL;
  • Fasting plasma glucose concentration \<126 mg/dl;
  • Willingness to eat the food provided in this study;
  • Subjects must be able to speak and understand English to participate in this study
  • Own a smartphone or other mobile device capable of downloading the Garmin Connect app.

Exclusion criteria

Exclusion Criteria:

  • Diagnoses of active malignancy, congestive heart failure, diabetes mellitus, chronic obstructive pulmonary disease, thyroid disease or other metabolic disorders that influence metabolism;
  • Evidence of impaired kidney function (Estimated glomerular filtration rate [eGFR] \<44 mL/min;
  • Regular use of medication that interferes with the measurement of study outcomes as determined by the study team (e.g., NSAIDs, corticosteroids);
  • Consuming >14 drinks per week of >4 drinks per night twice/week for male; >7 drinks per week or >3 drinks per night twice/week for female;
  • Use of cigarettes (or other tobacco products) or use of any other (recreational) drug in last 3 months;
  • Engaged in high-level competitive exercise (e.g., marathons, triathlons, cycling, weight-lifting competitions etc.)
  • Self-reported sleep duration \<5 hours per night;
  • Any inflammatory diseases (e.g. asthma, autoimmune diseases, coeliac disease, glomerulonephritis, hepatitis, inflammatory bowel disease, arthritis);
  • Use of antibiotics in last 30 days;
  • Pregnant or lactating women;
  • Eating disorders (e.g., anorexia nervosa, bulimia nervosa, binge eating disorders etc.)
  • Psychological disorders (e.g., clinical depression, bipolar disorders etc.);
  • Strict dietary patterns (e.g., vegan, carnivore, kosher, low-carb etc.);
  • History of stomach or bowel resection (other than appendectomy), gastric bypass or other bariatric weight loss procedure effecting absorption;
  • Persons who are not able to grant voluntary informed consent;
  • Persons who are unable or unwilling to follow the study protocol or who, for any reason, the research team considers not an appropriate candidate for this study, including non-compliance with screening appointments or study visits.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
21 participants (actual)

Study arms

  • Active comparator
    Traditional Diet

    Unprocessed/minimally processed whole foods.

    Dietary Supplement: Traditional Diet

  • Active comparator
    Modern Diet

    Multi-ingredient, ultra-processed formulations of the traditional diet.

    Dietary Supplement: Modern Diet

Interventions

  • Dietary supplementTraditional Diet

    Consuming an traditional whole foods based diet for 4 weeks.

  • Dietary supplementModern Diet

    Consuming an processed formulation of the traditional diet for 4 weeks.

06

What researchers measure

Primary outcomes

  1. Change in plasma interleukin-6 levels

    Plasma interleukin-6 levels will be measured before and after each diet

    Time frame: Baseline, up to 4 weeks.

  2. Change in plasma c-reactive protein levels

    Plasma c-reactive protein levels levels will be measured before and after each diet

    Time frame: Baseline, up to 4 weeks.

  3. Change in plasma acylcarnitine profiles

    Plasma acylcarnitines profiles levels will be measured before and after each diet

    Time frame: Baseline, up to 4 weeks.

Secondary outcomes

  1. Change in gut microbiota communities

    Bifidobacterium, Faecalibacterium prausnitzii, Anerostipes, Roseburia

    Time frame: Baseline, up to 4 weeks.

  2. Energy expenditure

    Measured by the doubly labeled water method during the last week of each diet

    Time frame: up to 4 weeks.

  3. Change in Neuroinflammation

    Neurofilament light (NfL), glial fibrillary acidic protein (GFAP), Aß42 and p-tau will be measured before and after each diet

    Time frame: Baseline, up to 4 weeks.

07

Study locations

1 site
  • Duke University School of Medicine
    Durham, North Carolina 27701, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 13, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04275843
Lead sponsor
Duke University
Collaborators
North Dakota Beef Commission
Responsible party
Sponsor
First posted
Feb 19, 2020
Start date
Oct 1, 2020
Primary completion
Dec 21, 2021
Completion
Dec 21, 2021
Last update
Jul 13, 2022

Study contacts

Stephan van Vliet, PhD
study director · Duke University
Kim Huffman, MD, PhD
principal investigator · Duke University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion